Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / CHMA - Chiasma: Undervalued Despite Approval And Market Potential Of MYCAPSSA

CHMA - Chiasma: Undervalued Despite Approval And Market Potential Of MYCAPSSA

Chiasma Inc.
  • CHMA's MYCAPSSA was approved and launched last year for acromegaly.
  • MYCAPSSA is an oral formulation of a well-known injection.
  • The market potential runs into hundreds of millions of dollars, and yet, the stock seems depressed.

For further details see:

Chiasma: Undervalued Despite Approval And Market Potential Of MYCAPSSA
Stock Information
Company Name: Chiasma Inc.
Stock Symbol: CHMA
Market: NASDAQ
Website: chiasmapharma.com
Menu
CHMA CHMA Quote CHMA Short CHMA News CHMA Articles CHMA Message Board
Get CHMA Alerts

News, Short Squeeze, Breakout and More Instantly...